Rylaze Injection
Product Images NDC 68727-900

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Rylaze (NDC 68727-900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jazz Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton Label)

The text appears to be a product description for Asparaginase Erwinia Chrysanthemi (recombinant)-rywn. It contains dosage and administration instructions, storage guidelines, manufacturer information, and a National Drug Code (NDC). The product is an injection used for intramuscular use and comes in a 10 mg/0.5 mL dosage. It is stored refrigerated at 2°C to 8°C and must be protected from shaking or freezing. Unused portions should be discarded, and there is no US standard of potency for the product.*

FDA Label Image

Vial (Vial Label)

RYLAZE™ is a medication with NDC 68727-900-01 for intramuscular use. The dosage information is available in the prescribing information. The drug contains ginase erwiniachrysanthemi and Ibinant-Tywn at 10 mg/o.5mL. It has to be stored refrigerated at 2°C'to 8°C (36°F to 46°F), and the lot number is XXXXX. The manufacturer is Jazz Pharmaceuticals Ireland Limited, and the product has a US license number of 2167.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.